Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Eur J Phys Rehabil Med ; 47(2): 281-96, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21555985

ABSTRACT

Hip fracture (HF) is a common event in the geriatric population and is often associated with significant morbidity, mortality and costs for the Healthcare Systems. The growing awareness of HF consequences and the expected rise in the total number of HF worldwide have led to the development and implementation of models of care alternative to the traditional ones for the acute and post-acute management of HF older adults. These services were set to minimize in-hospital complications, streamline hospital care and provide early discharge with the main objectives of improving functional and clinical outcomes, and reducing healthcare costs associated with hip and other fractures. Basically, the main feature that distinguishes these models is the different healthcare professional that retains the responsibility of the care during the acute and postacute phases. This review has been conceived to provide a brief description of the models implemented in the last twenty years, to describe their potential benefits on short- and long-term outcomes, to define the strengths and limitations of these models and the areas of uncertain, and to make some consideration about the future. Actually, on the basis of available studies, it is not possible to define the best model of care for HF older adults. However, the more complex and sophisticated services, characterized by a multidisciplinary approach demonstrated, in randomized-controlled and before-after observational studies, to produce better outcomes compared to the traditional or simplest models. Further research is warranted to confirm long-term functional and clinical benefits of these models and to evaluate their cost-effectiveness.


Subject(s)
Delivery of Health Care, Integrated/standards , Hip Fractures/rehabilitation , Home Care Services/organization & administration , Patient Care Team/organization & administration , Patient Discharge/standards , Aged , Aged, 80 and over , Critical Pathways , Delivery of Health Care, Integrated/organization & administration , Female , Geriatrics , Hip Fractures/complications , Hip Fractures/epidemiology , Home Care Services/standards , Humans , Interdisciplinary Communication , Male , Orthopedics , Patient Care Team/standards , Patient Discharge/trends , Standard of Care , Time Factors
2.
J Endocrinol Invest ; 29(9): 809-13, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17114912

ABSTRACT

OBJECTIVES: To determine and compare the prevalence of secondary hyperparathyroidism (HPTH) in a population of community-dwelling and institutionalized older adults hospitalized with and without hip fracture, and to evaluate factors correlated with secondary HPTH in this population. METHODS: Circulating concentrations of serum intact PTH, 25-hydroxyvitamin D [25(OH)D] total serum calcium and albumin were measured in 160 subjects with an osteoporotic fracture of the proximal femur and in 160 matched controls hospitalized for a disease unrelated to bone status. Patients with secondary causes of bone loss and taking medications affecting bone metabolism were excluded. Age, sex, place of residence and the ability to perform basic activities of daily living (BADL) two weeks before hospital admission were recorded at baseline. RESULTS: Patients were comparable with regard to the baseline demographic, biochemical and functional characteristics. The overall prevalence of secondary hyperparathyroidism was 51.2%, without significant differences between hip fractured patients and controls (50.6 vs 51.9%, p=0.911). In bivariate analysis only the age and functional status (BADL) demonstrated a significant relationship with secondary HPTH, while sex and place of residence were not significant. These results were also confirmed in multivariate analysis. Particularly, the risk of secondary HPTH increased with age and with the number of functions lost in BADL: patients fully dependent showed a 3 times as high risk (odd ratio 3.07, 95% confidence interval 1.73 to 5.46, p=0.000) compared to patients independent in BADL, and subject aged >88 yr had a twice as high risk of developing secondary HPTH compared to younger ones (odd ratio 2.28, 95% confidence interval 1.20 to 4.32, p=0.012). CONCLUSION: These results show that secondary HPTH due to hypovitaminosis D is a frequent disorder in hospitalized elderly, strongly correlated with the functional status, irrespective of sex and place of residence.


Subject(s)
Hip Fractures/epidemiology , Hyperparathyroidism, Secondary/epidemiology , Hyperparathyroidism, Secondary/etiology , Vitamin D Deficiency/complications , Aged , Aged, 80 and over , Albumins/analysis , Calcium/blood , Case-Control Studies , Female , Hip Fractures/blood , Hip Fractures/etiology , Humans , Hyperparathyroidism, Secondary/blood , Male , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/complications , Osteoporosis, Postmenopausal/epidemiology , Parathyroid Hormone/blood , Prevalence , Residence Characteristics , Vitamin D/analogs & derivatives , Vitamin D/blood , Vitamin D Deficiency/blood , Vitamin D Deficiency/epidemiology
3.
Dent Clin North Am ; 44(2): 427-38, viii, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10740777

ABSTRACT

Digital radiographic imaging in dentistry has matured. All the reasons dentists have cited for keeping conventional, film-based systems have been refuted: cost, sensors, storage, and training are not issues. There are many reasons to switch to digital. This article outlines external factors that dentists may not have considered that will influence the way they conduct business in their offices related to radiographic imaging. The evidence points to the inevitable adoption of digital imaging systems.


Subject(s)
Radiography, Dental, Digital/trends , Costs and Cost Analysis , Education, Dental , Education, Distance , Equipment Design , Forecasting , Humans , Information Storage and Retrieval/economics , Internet , Practice Management, Dental/economics , Radiography, Dental/economics , Radiography, Dental, Digital/economics , Radiography, Dental, Digital/instrumentation , Remote Consultation , X-Ray Film
4.
Leuk Lymphoma ; 10(1-2): 127-34, 1993 May.
Article in English | MEDLINE | ID: mdl-8374520

ABSTRACT

To evaluate its clinical efficacy as well as its biologic safety, human recombinant Erythropoietin (rh-Epo) was given to 19 patients with myelodysplastic syndromes (MDS) in an open non-randomized study. Among the seventeen evaluable patients only two showed an apparent hematologic response to rh-Epo treatment. In these patients hemoglobin levels increased from a mean pretreatment value of 8.5 and 8.4 g/dl up to 11.7 and 11.3 g/dl respectively and remained relatively stable for several weeks. In one of these patients the transfusion requirement decreased from 4 to 1.5 units per month whereas the other had no transfusion requirement during the whole period of rh-Epo treatment. Interestingly, when the responding patients, after a "wash-out" period of at least ten weeks, received an additional course of rh-Epo results were less impressive. Before treatment the serum level of endogenous Epo was 18 and 110 mU/ml in the two responding patients, whereas a mean value of 532 mU/ml (range 17-2797 mU/ml) was observed in non responders. The treatment of MDS patients with rh-Epo was clinically well tolerated since no relevant side effects were registered. Moreover, no evidence of harmful cytogenetic changes nor activation of myeloid growth factor genes, as determined by Northern blot analysis of GM-CSF and G-CSF gene expression, could be related to rh-Epo treatment. Overall, it appears that administration of rh-Epo is well tolerated but the therapeutic effects appear to be restricted to a minority of patients and a limited period of time.


Subject(s)
Erythropoietin/therapeutic use , Myelodysplastic Syndromes/drug therapy , Aged , Aged, 80 and over , Cytokines/genetics , Erythropoietin/adverse effects , Erythropoietin/pharmacology , Female , Gene Expression/drug effects , Humans , Male , Middle Aged , Recombinant Proteins/therapeutic use
8.
Am J Hematol ; 34(1): 37-43, 1990 May.
Article in English | MEDLINE | ID: mdl-2327403

ABSTRACT

We studied by cytochemical means the distribution of 5' nucleotidase (5' NT), a purine degradative enzyme, in the circulating lymphocytes of 24 healthy donors and 41 cases of chronic lymphoid leukemias, classified according to morphological and immunological criteria. About half the normal circulating lymphocytes were 5'NT positive and exhibited variable degrees of enzyme activity. Among chronic B lymphocytic leukemias we found high percentages of positive cells only in the phenotypically more mature cases. Moreover all cases of hairy cell, follicular cell, lymphoplasmacytic, and plasma cell leukemia showed moderate or weak 5' NT reactivity. Also one case of chronic T lymphocytic leukemia, CD8 positive, was moderately positive, while another, with large granular lymphocyte morphology, was completely negative. Electron microscopy revealed a discontinuous, granular plasma membrane reaction pattern, varying in intensity from case to case. In conclusion, our results confirm the usefulness of the 5' NT cytochemical reaction for identification of lymphoid populations at different stages of maturation in chronic B cell disorders.


Subject(s)
5'-Nucleotidase/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell/enzymology , Adult , Aged , Aged, 80 and over , Female , Histocytochemistry , Humans , Leukemia, Hairy Cell/enzymology , Leukemia, Hairy Cell/pathology , Leukemia, Lymphocytic, Chronic, B-Cell/classification , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Lymphocytes/enzymology , Lymphocytes/pathology , Lymphocytes/ultrastructure , Lymphoma, Non-Hodgkin/enzymology , Lymphoma, Non-Hodgkin/pathology , Male , Microscopy, Electron , Middle Aged , Phenotype
9.
Ital J Orthop Traumatol ; 13(1): 67-71, 1987 Mar.
Article in English | MEDLINE | ID: mdl-3692799

ABSTRACT

The authors describe a rare case of osteogenesis imperfecta in a patient aged 29 years affected with equal deformities of the lower extremities. In the right tibia a pseudarthrosis due to a fatigue fracture had occurred at the apex of the deformity. Treatment by the traditional methods posed serious problems, both technical and from the point of view of repair of the pseudarthrosis and the trophic changes. These problems were solved by using the Ilizarov compression-extension apparatus.


Subject(s)
Orthopedic Fixation Devices , Osteogenesis Imperfecta/therapy , Adult , Casts, Surgical , Female , Fractures, Spontaneous/complications , Humans , Osteogenesis Imperfecta/complications , Pseudarthrosis/etiology , Pseudarthrosis/therapy , Tibial Fractures/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...